Related Experiment Video
Updated: Jan 8, 2026

A High-throughput Platform for the Screening of Salmonella spp./Shigella spp.
Published on: November 7, 2018
State-of-the-Art Review: Infectious Diarrhea
Andi L Shane1, Mark D Gonzalez2, Amanda M Roy3
1Division of Pediatric Infectious Disease, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
None:
In this review, we describe a multidisciplinary approach to the care of a patient with diarrhea, known or suspected to be the result of an infection, incorporating infectious disease, gastroenterology, microbiology, and pharmacy clinical perspectives. We highlight updates in the epidemiology and etiologies of infectious diarrhea, considering both the individual and community impact of disease burden since the publication of the 2017 Infectious Diseases Society of America endorsed guidelines addressing the management of infectious diarrhea. We consider the acute, chronic, and post-infectious intestinal and extra-intestinal manifestations of infectious diarrhea and the clinical challenges posed by each. We discuss the role of diagnostics, including molecular-based testing, often referred to as culture independent diagnostic testing, and culture-based platforms and their role in clinical care and public health surveillance. We discuss emerging antimicrobial resistance and the role of biotherapeutics as strategies to decrease the burden of infectious diarrhea.
More Related Videos
04:56Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
03:25Author Spotlight: Exploring Non-Pharmacological Therapies for Chronic Respiratory Diseases — Linking Intestinal Microbiome Insights to COPD Treatment
Published on: December 27, 2024
Related Concept Videos
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...